A Study of KHK4827 in Patients With Systemic Sclerosis

NCT04368403 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Sclerosis

Interventions

DRUG: KHK4827

Sponsor

Kyowa Kirin Co., Ltd.